SK94297A3 - New applications of lysozyme dimer - Google Patents

New applications of lysozyme dimer Download PDF

Info

Publication number
SK94297A3
SK94297A3 SK942-97A SK94297A SK94297A3 SK 94297 A3 SK94297 A3 SK 94297A3 SK 94297 A SK94297 A SK 94297A SK 94297 A3 SK94297 A3 SK 94297A3
Authority
SK
Slovakia
Prior art keywords
use according
group
lysozyme
lysozyme dimer
klp
Prior art date
Application number
SK942-97A
Other languages
English (en)
Slovak (sk)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of SK94297A3 publication Critical patent/SK94297A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fish Paste Products (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK942-97A 1995-01-13 1996-01-13 New applications of lysozyme dimer SK94297A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07
PCT/EP1996/000135 WO1996021463A2 (en) 1995-01-13 1996-01-13 New applications of lysozyme dimer

Publications (1)

Publication Number Publication Date
SK94297A3 true SK94297A3 (en) 1998-01-14

Family

ID=26138401

Family Applications (1)

Application Number Title Priority Date Filing Date
SK942-97A SK94297A3 (en) 1995-01-13 1996-01-13 New applications of lysozyme dimer

Country Status (38)

Country Link
EP (2) EP0804227B1 (cs)
JP (1) JPH10511974A (cs)
KR (1) KR100420377B1 (cs)
CN (1) CN1090506C (cs)
AP (2) AP628A (cs)
AT (1) ATE218367T1 (cs)
AU (1) AU709620B2 (cs)
BA (1) BA96074A (cs)
BG (1) BG62239B1 (cs)
BR (1) BR9606973A (cs)
CA (1) CA2210091A1 (cs)
CZ (1) CZ293353B6 (cs)
DE (2) DE69621589D1 (cs)
DZ (1) DZ1964A1 (cs)
EA (1) EA001462B1 (cs)
EE (1) EE9700154A (cs)
ES (1) ES2109208T1 (cs)
FI (1) FI972943A0 (cs)
GB (1) GB2311724B (cs)
GE (1) GEP20012571B (cs)
GR (1) GR970300047T1 (cs)
HK (1) HK1002060A1 (cs)
HR (1) HRP960014A2 (cs)
HU (1) HU223903B1 (cs)
IL (1) IL116737A (cs)
MA (1) MA23775A1 (cs)
MD (1) MD1633C2 (cs)
MY (1) MY132437A (cs)
NO (1) NO973203D0 (cs)
NZ (1) NZ298432A (cs)
OA (1) OA10436A (cs)
PL (1) PL185678B1 (cs)
SK (1) SK94297A3 (cs)
SV (1) SV1996000001A (cs)
TN (1) TNSN96004A1 (cs)
TR (1) TR199700633T1 (cs)
UA (1) UA50728C2 (cs)
WO (1) WO1996021463A2 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
DE69900754T2 (de) * 1998-04-27 2002-08-22 Nika Health Products Ltd., Vaduz Zusammensetzung zur verbesserung der fruchtbarkeit und ihre verwendung
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
WO2008109401A2 (en) * 2007-03-02 2008-09-12 Saint Simeon Lda Composition and method for treating papilloma virus and equine sarcoids
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
PL3082837T3 (pl) 2013-12-18 2021-02-08 Dsm Ip Assets B.V. Kompozycje zawierające hydrolizat lizozymu do zastosowania w tkance zawierającej keratynę
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
EP0181634A3 (en) * 1984-11-14 1987-09-09 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
WO1988005783A1 (en) * 1987-01-28 1988-08-11 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
RO114805B1 (ro) * 1990-01-08 1999-07-30 Nika Health Products Ltd Vaduz Dimer de lizozim purificat si procedeu de obtinere a acestuia
JP2732515B2 (ja) * 1990-01-08 1998-03-30 ニカ ヘルス プロダクツ リミテッド リボヌクレアーゼ二量体の製造方法
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Also Published As

Publication number Publication date
DZ1964A1 (fr) 2002-10-15
OA10436A (en) 2001-12-07
MD970244A (en) 1999-05-31
PL321546A1 (en) 1997-12-08
NO973203L (no) 1997-07-10
FI972943A (fi) 1997-07-11
CZ293353B6 (cs) 2004-04-14
ATE218367T1 (de) 2002-06-15
BR9606973A (pt) 1999-01-26
BA96074A (bs) 1999-08-02
MA23775A1 (fr) 1996-10-01
HRP960014A2 (en) 1997-12-31
WO1996021463A3 (en) 1996-09-19
TNSN96004A1 (fr) 2005-03-15
HU223903B1 (hu) 2005-03-29
MD1633C2 (ro) 2001-10-31
AP871A (en) 2000-09-10
EP1086703A2 (en) 2001-03-28
KR19980701337A (ko) 1998-05-15
AU4391696A (en) 1996-07-31
EP0804227B1 (en) 2002-06-05
ES2109208T1 (es) 1998-01-16
EA199700101A1 (ru) 1997-12-30
WO1996021463A2 (en) 1996-07-18
CA2210091A1 (en) 1996-07-18
AU709620B2 (en) 1999-09-02
EP1086703A3 (en) 2001-05-02
GB2311724A (en) 1997-10-08
BG62239B1 (bg) 1999-06-30
TR199700633T1 (xx) 1998-01-21
CZ220297A3 (cs) 1998-02-18
EP0804227A2 (en) 1997-11-05
SV1996000001A (es) 1997-02-17
NZ298432A (en) 2001-03-30
AP9701024A0 (en) 1997-07-31
FI972943A0 (fi) 1997-07-11
HUP9801689A2 (hu) 1998-10-28
PL185678B1 (pl) 2003-07-31
DE804227T1 (de) 1998-04-09
GR970300047T1 (en) 1997-12-31
GEP20012571B (en) 2001-11-26
HK1002060A1 (en) 1998-07-31
IL116737A (en) 2000-02-17
GB9714354D0 (en) 1997-09-10
DE69621589D1 (de) 2002-07-11
MD1633B2 (en) 2001-03-31
EE9700154A (et) 1997-12-15
CN1177303A (zh) 1998-03-25
HUP9801689A3 (en) 2000-07-28
MY132437A (en) 2007-10-31
NO973203D0 (no) 1997-07-10
UA50728C2 (uk) 2002-11-15
JPH10511974A (ja) 1998-11-17
KR100420377B1 (ko) 2004-05-20
GB2311724B (en) 1999-07-21
CN1090506C (zh) 2002-09-11
AP9600783A0 (en) 1996-04-30
BG101709A (en) 1998-03-31
EA001462B1 (ru) 2001-04-23
IL116737A0 (en) 1996-05-14
AP628A (en) 1998-02-27

Similar Documents

Publication Publication Date Title
JP2962555B2 (ja) 溶菌ペプチドによる真核性病原体と新生物の抑制及び繊維芽細胞とリンパ球の刺激
Kohchi et al. Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory
AP871A (en) New applicants of lysozyme dimer.
Vakhidova et al. FUNGI OF THE GENUS PAECILOMYCES AND THEIR ROLE IN DEVELOPMENT ECHINOCOCCOSIS
US4842862A (en) Immunostimulating agents
CN1057937C (zh) 溶菌酵素二聚体的新用途及其含有溶菌酵素二聚体的制剂
US6183742B1 (en) Applications of lysozyme dimer
CN111514157A (zh) 组合物在制备兽用抗寄生虫病药物中的应用、兽用抗寄生虫病的透皮溶液及其制备方法
JPH07508010A (ja) DNAウイルス感染の治療のための薬物の製造のための膜翅類昆虫(hymenoptera)毒の使用
KR101418881B1 (ko) 면역증강, 염증치료 및 통증치료용 수지봉독과 이를 이용한 비경구 투여용 조성물 및 그 제조방법
KR20060038387A (ko) 화학요법을 받고 있는 암 환자를 치료하는 방법
US20020098171A1 (en) New application of lysozyme dimer
MXPA97005246A (en) New applications of dimero de lisoz
RU2527329C2 (ru) Способ получения комплексного иммунометаболического препарата с антиинфекционной активностью
RU2620548C1 (ru) Способ профилактики респираторных болезней телят
RU2136303C1 (ru) Способ получения средства для лечения ларвального и стробилярного эхинококкозов "чеблин ск-1"
RU1818095C (ru) Препарат дл профилактики и лечени бронхопневмании сельскохоз йственных животных
Yagupsky et al. Relapse of Israeli spotted fever treated with doxycycline
Bogach et al. DETERMINATION OF THE CHRONIC TOXICITY PARAMETERS OF THE COMPLEX REMEDY FOR THE TREATMENT OF CYSTICERCOSIS IN RABBITS
Broshkov et al. METHODS FOR REGULATION OF IMMUNE REACTIVITY IN DOGS: a monograph
SU1651905A1 (ru) Способ лечени дикроцелиоза овец
WO2005042015A1 (fr) Composition pharmaceutique anti-herpetique, procede de production d'une forme medicamenteuse a partir de cette composition et procede d'utilisation correspondant
RU2256460C2 (ru) Способ лечения неспецифической бронхопневмонии у телят
RU2117485C1 (ru) Средство для профилактики и лечения пневмоэнтеритов поросят - препарат "живая кровь"
RU2067865C1 (ru) Способ лечения и профилактики инвазионных заболеваний